Patents by Inventor Keith Stubbs

Keith Stubbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS
    Publication number: 20230365493
    Abstract: Compounds of Formula (A) and methods for use as agricultural chemicals, including herbicides.
    Type: Application
    Filed: September 8, 2021
    Publication date: November 16, 2023
    Inventors: Joshua Scott MYLNE, Keith STUBBS, Joel HAYWOOD, Karen BREESE
  • Selective glycosidase inhibitors and uses thereof
    Patent number: 8962664
    Abstract: The invention provides compounds of formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: February 24, 2015
    Assignee: Simon Fraser University
    Inventors: David Vocadlo, Ernest McEachern, Keith Stubbs, Tong-Shuang Li, Garrett Whitworth, Julia Heinonen, Matthew Macauley
  • Selective Glycosidase Inhibitors and Uses Thereof
    Publication number: 20140051719
    Abstract: The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
    Type: Application
    Filed: August 15, 2013
    Publication date: February 20, 2014
    Applicant: Simon Fraser University
    Inventors: David Jaro Vocadlo, Ernest John McEachern, Keith Stubbs
  • Selective glycosidase inhibitors and uses thereof
    Patent number: 8541441
    Abstract: The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: September 24, 2013
    Assignee: Simon Fraser University
    Inventors: David Jaro Vocadlo, Ernest John McEachern, Keith Stubbs
  • Selective glycosidase inhibitors and uses thereof
    Patent number: 8334310
    Abstract: The invention provides compounds of formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: December 18, 2012
    Assignee: Simon Fraser University
    Inventors: David Vocadlo, Ernest McEachern, Keith Stubbs, Tong-Shuang Li, Garrett Whitworth, Julia Heinonen, Matthew Macauley
  • SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF
    Publication number: 20120316207
    Abstract: The invention provides compounds of formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 13, 2012
    Applicant: Simon Fraser University
    Inventors: David Vocadlo, Ernest McEachern, Keith Stubbs, Tong-Shuang Li, Garrett Whitworth, Julia Heinonen, Matthew Macauley
  • Selective Glycosidase Inhibitors and Uses Thereof
    Publication number: 20120095033
    Abstract: The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
    Type: Application
    Filed: July 31, 2009
    Publication date: April 19, 2012
    Applicant: SIMON FRASER UNIVERSITY
    Inventors: David Jaro Vocadlo, Ernest John Mceachern, Keith Stubbs
  • Targeted regression testing
    Patent number: 7779303
    Abstract: A software testing method. In particular implementations, a method includes accessing a first database of one or more bug entries, wherein each bug entry comprises information characterizing a bug, an associated code component, and a test script; and a mapping between the component and one or more scripts that test the code component; for one or more bug entries in the first database, determining if the bug is a new bug; if the bug is not a new bug, determining if the test script is new relative to the bug; and if the bug is a new bug or if the test script is new relative to the bug, accessing a second database of the script-to-component mappings to add a mapping between the test script and the associated code component of a respective bug entry.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: August 17, 2010
    Assignee: Cisco Technology, Inc.
    Inventors: Keith Stubbs, Madhuri Vemulakonda
  • SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF
    Publication number: 20100016386
    Abstract: The invention provides compounds of formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc
    Type: Application
    Filed: August 31, 2007
    Publication date: January 21, 2010
    Inventors: David Vocadlo, Ernest McFachern, Keith Stubbs, Tong-Shuang Li, Garrett Whitworth, Julia Heinonen, Matthew Macauley
  • Targeted Regression Testing
    Publication number: 20080209276
    Abstract: A software testing method. In particular implementations, a method includes accessing a first database of one or more bug entries, wherein each but entry comprises information characterizing a bug, an associated code component, and a test script; and a mapping between the component and one or more scripts that test the code component; for one or more bug entries in the first database, determining if the bug is a new bug; if the bug is not a new bug, determining if the test script is new relative to the bug; and if the bug is a new bug or if the test script is new relative to the bug, accessing a second database of the script to component mappings to add a mapping between the test script and the associated code component of a respective bug entry.
    Type: Application
    Filed: February 27, 2007
    Publication date: August 28, 2008
    Applicant: Cisco Technology, Inc.
    Inventors: Keith Stubbs, Madhuri Vemulakonda